共 133 条
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - A systematic review of in vitro data
被引:288
作者:
Doktorovova, Slavomira
[1
,2
]
Souto, Eliana B.
[2
,3
]
Silva, Amelia M.
[1
,4
]
机构:
[1] Univ Tras Os Montes & Alto Douro, Sch Life & Environm Sci, ECVA, UTAD,Dept Biol & Environm, P-5001801 Vila Real, Portugal
[2] Univ Tras Os Montes & Alto Douro, Inst Biotechnol & Bioengn, Ctr Genom & Biotechnol, IBB CGB UTAD, Vila Real, Portugal
[3] Fernando Pessoa Univ, Dept Pharmaceut Technol, UFP, Porto, Portugal
[4] Univ Tras Os Montes & Alto Douro, Ctr Res & Technol Agroenvironm & Biol Sci, CITAB UTAD, Vila Real, Portugal
关键词:
Lipid nanoparticles;
Solid lipid nanoparticles;
Nanostructured lipid carriers;
Cytotoxicity;
Genotoxicity;
Oxidative stress;
Blood compatibility;
In vitro studies;
OF-THE-ART;
CELLULAR UPTAKE;
DRUG-DELIVERY;
PHYSICOCHEMICAL CHARACTERISTICS;
MULTIDRUG-RESISTANCE;
ANTIOXIDANT ACTIVITY;
ANTICANCER ACTIVITY;
CYTOKINE PRODUCTION;
REVERSAL ACTIVITY;
PHAGOCYTIC UPTAKE;
D O I:
10.1016/j.ejpb.2014.02.005
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were developed as alternative to other colloidal carriers. They were designed to overcome lipid nanoemulsions and liposomes in stability and ability to control the release of an encapsulated substance, and at the same time to be better tolerated than polymeric nanoparticles. Since the patenting of SLN discovery, large amount of data became available on the behaviour of these systems in vitro. SLN/NLC have many prerequisites to be a well tolerated carrier - the currently available data seem to confirm it, but there are also some contradictory results. In this review, we collected the available data from cytotoxicity, oxidative stress and hemocompatibility studies in vitro and analysed their outcomes. We also provide a summary of the available data in a form of reference table. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 18
页数:18
相关论文